EcoDrugPlus

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSBGRG00000015440
Gene Symbol: EGLN2
1 Cross references
192 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSBGRG00000009029
Gene Symbol: EGLN3
1 Cross references
208 Possible Orthologues:

Elastase, Neutrophil Expressed

Ensembl ID : ENSBGRG00000007765
Gene Symbol: ELANE
1 Cross references
91 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSBGRG00000006847
Gene Symbol: EPAS1
1 Cross references
225 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSBGRG00000000770
Gene Symbol: ECE1
1 Cross references
230 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSBGRG00000009303
Gene Symbol: EDNRA
1 Cross references
270 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSBGRG00000020314
Gene Symbol: EDNRB
1 Cross references
267 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSBGRG00000013158
Gene Symbol: EZH2
1 Cross references
235 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSBGRG00000000999
Gene Symbol: EPHX2
1 Cross references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSBGRG00000023607
Gene Symbol: ERBB2
1 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSBGRG00000000947
Gene Symbol: ERBB3
1 Cross references
280 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSBGRG00000003801
Gene Symbol: ERBB4
1 Cross references
320 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).